Vidak, M.; Jovcevska, I.; Samec, N.; Zottel, A.; Liovic, M.; Rozman, D.; Dzeroski, S.; Juvan, P.; Komel, R.
Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates. Int. J. Mol. Sci. 2018, 19, 1369.
https://doi.org/10.3390/ijms19051369
AMA Style
Vidak M, Jovcevska I, Samec N, Zottel A, Liovic M, Rozman D, Dzeroski S, Juvan P, Komel R.
Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates. International Journal of Molecular Sciences. 2018; 19(5):1369.
https://doi.org/10.3390/ijms19051369
Chicago/Turabian Style
Vidak, Marko, Ivana Jovcevska, Neja Samec, Alja Zottel, Mirjana Liovic, Damjana Rozman, Saso Dzeroski, Peter Juvan, and Radovan Komel.
2018. "Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates" International Journal of Molecular Sciences 19, no. 5: 1369.
https://doi.org/10.3390/ijms19051369
APA Style
Vidak, M., Jovcevska, I., Samec, N., Zottel, A., Liovic, M., Rozman, D., Dzeroski, S., Juvan, P., & Komel, R.
(2018). Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates. International Journal of Molecular Sciences, 19(5), 1369.
https://doi.org/10.3390/ijms19051369